Skip to main content

and
  1. Article

    Open Access

    Prevalence of pathogenic germline variants in the circulating tumor DNA testing

    Somatic and germline variants are not distinguishable by circulating tumor DNA (ctDNA) testing without analyzing non-tumor samples. Although confirmatory germline testing is clinically relevant, the criteria f...

    Yoshihiro Yamamoto, Keita Fukuyama in International Journal of Clinical Oncology (2022)

  2. No Access

    Article

    Germline sequencing for presumed germline pathogenic variants via tumor-only comprehensive genomic profiling

    The European Society for Medical Oncology Precision Medicine Working Group (ESMO-PMWG) published recommendations regarding confirmatory germline testing for presumed germline pathogenic variants (PGPVs) in tum...

    Tomohiro Kondo, Yoshihiro Yamamoto in International Journal of Clinical Oncology (2022)

  3. No Access

    Article

    Qualitative and Quantitative Analysis of Posttreatment Strategy After Endoscopic Resection for Patients with T1 Colorectal Cancer at High Risk of Lymph Node Metastasis

    Although endoscopic resection is increasingly performed to treat submucosal invasive colorectal cancer (T1CRC), approximately 10% are at risk of lymph node metastasis. The Japanese Society for Cancer of the Co...

    Yoshitaka Nishikawa, Takahiro Horimatsu in Journal of Gastrointestinal Cancer (2020)

  4. Article

    Open Access

    Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells

    Epidermal growth factor receptor (EGFR) plays a pivotal role in the pathophysiology of esophageal squamous cell carcinoma (ESCC). However, the clinical effects of EGFR inhibitors on ESCC are controversial. Thi...

    Masahiro Yoshioka, Shinya Ohashi, Tomomi Ida in Journal of Experimental & Clinical Cancer … (2017)